Necuparanib Uses, Dosage, Side Effects and more
Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).
| Trade Name | Necuparanib |
| Generic | Necuparanib |
| Necuparanib Other Names | M-402 free acid, Necuparanib |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
